Found: 14
Select item for more details and to access through your institution.
Efficacy of rifaximin, a poorly absorbed rifamycin antimicrobial agent, for hepatic encephalopathy in Japanese patients.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 445, doi. 10.1111/hepr.13622
- By:
- Publication type:
- Article
Role of serum albumin in hepatic encephalopathy.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 353, doi. 10.1111/hepr.13632
- By:
- Publication type:
- Article
Comparison of the efficacy and safety of conventional transarterial chemoembolization with and without drug‐eluting beads embolization for the treatment of unresectable large hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 482, doi. 10.1111/hepr.13620
- By:
- Publication type:
- Article
Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavir.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 503, doi. 10.1111/hepr.13618
- By:
- Publication type:
- Article
Report of the 21st Nationwide Follow‐up Survey of Primary Liver Cancer in Japan (2010–2011).
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 355, doi. 10.1111/hepr.13612
- By:
- Publication type:
- Article
Potential of ultra‐highly sensitive immunoassays for hepatitis B surface and core‐related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 426, doi. 10.1111/hepr.13602
- By:
- Publication type:
- Article
Severity of liver fibrosis using shear wave elastography is influenced by hepatic necroinflammation in chronic hepatitis patients, but not in cirrhotic patients.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 436, doi. 10.1111/hepr.13617
- By:
- Publication type:
- Article
Hepatitis B vaccination policies for health‐care workers: Need for a worldwide consensus.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 509, doi. 10.1111/hepr.13615
- By:
- Publication type:
- Article
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 406, doi. 10.1111/hepr.13600
- By:
- Publication type:
- Article
Multicenter prospective study of stereotactic body radiotherapy for previously untreated solitary primary hepatocellular carcinoma: The STRSPH study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 461, doi. 10.1111/hepr.13595
- By:
- Publication type:
- Article
Characteristics of patients aged over 75 years with hepatitis C virus infection treated with direct‐acting antivirals in Japan: Evidence based on the nationwide, real‐world database in Japan.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 417, doi. 10.1111/hepr.13596
- By:
- Publication type:
- Article
Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular‐targeted agent sequential therapy: A propensity score‐matched analysis.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 472, doi. 10.1111/hepr.13597
- By:
- Publication type:
- Article
Metabolomic profiles of breath odor compounds for prognostic prediction in patients with acute‐on‐chronic liver failure: A pilot study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 490, doi. 10.1111/hepr.13594
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 351, doi. 10.1111/hepr.13516
- Publication type:
- Article